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Abstract
Background: IL-9 is a growth factor for T- and mast-cells that is secreted by human Th2 cells. We recently reported that IL-
4+TGF-b directs mouse CD4+CD252CD62L+ T cells to commit to inflammatory IL-9 producing CD4+ T cells.
Methodology/Principal Findings: Here we show that human inducible regulatory T cells (iTregs) also express IL-9. IL-4+TGF-b
induced higher levels of IL-9 expression in plate bound-anti-CD3 mAb (pbCD3)/soluble-anti-CD28 mAb (sCD28) activated human
resting memory CD4+CD252CD45RO+ T cells as compared to naı¨ve CD4+CD252CD45RA+ T cells. In addition, as compared to
pbCD3/sCD28 plus TGF-b stimulation, IL-4+TGF-b stimulated memory CD4+CD252CD45RO+ T cells expressed reduced FOXP3
protein. As analyzed by pre-amplification boosted single-cell real-time PCR, human CD4+IL-9+ T cells expressed GATA3 and RORC,
but not IL-10, IL-13, IFNc or IL-17A/F. Attempts to optimize IL-9 production by pbCD3/sCD28 and IL-4+TGF-b stimulated resting
memory CD4+ T cells demonstrated that the addition of IL-1b, IL-12, and IL-21 further enhance IL-9 production.
Conclusions/Significance: Taken together these data show both the differences and similarities between mouse and
human CD4+IL9+ T cells and reaffirm the powerful influence of inflammatory cytokines to shape the response of activated
CD4+ T cells to antigen.
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Introduction
Cytokines present within the milieu in which human naı¨ve
CD4+ T cells are activated via stimulation of the TCR complex
and co-stimulatory molecules dictate whether these cells commit to
Th1, Th2, Th17 or regulatory (Treg) T cell phenotype [1–4]. The
commitment of mouse and human CD4+ T cells to such distinct
phenotypes is directed through expression of lineage specific
transcription factors, e.g., Tbet for Th1, GATA3 for Th2, and
RORct for Th17 cells [5–7]. While IL-4 and TGF-b respectively
direct activated mouse and human naı¨ve CD4+ T cells to commit
to the Th2 or inducible Treg (iTreg) phenotypes, the presence of
IL-4+TGF-b directs mouse CD4+CD252CD62L+ T cells or
CD4+CD252CD44low T cells to commit to supposedly a novel
inflammatory IL-9 producing CD4+ T cell subset (‘‘Th9’’) [8–10].
Mouse studies did not examine the effects of IL-4+TGF-b in
fostering commitment of naı¨ve CD4+CD252CD62LhighCD44low
versus resting memory CD4+CD252CD62LlowCD44high T cells to
CD4+IL-9+ T cells [8,10]. IL-9 was initially cloned as a T-cell
growth factor and IL-9 receptor shares the common c-chain with
other IL-2 family members IL-2, -4, -7, -15, and -21 [11,12]. It is
yet to be examined if IL-4+TGF-b induce a ‘‘Th9’’ like subset in
humans.
We hypothesized that IL-4+TGF-b in the setting of plate
bound-anti-CD3 mAb (pbCD3)/soluble-anti-CD28 mAb (sCD28)
stimulation fosters commitment of human naı¨ve and resting
memory CD4+CD252 T cells to express IL-9. Our analysis which
includes a successful effort to optimize IL-9 expression or
frequency of CD4+IL-9+ T cells and their molecular phenotype
reveals both similarities and distinctions between human and
murine IL-9+ T cells. In addition, we have determined that resting
and memory CD4+ T cells are not equal in their frequency to
express IL-9. While examining the requirements to optimize
generation of human CD4+IL-9+ T cells, we found that IL-1b, IL-
12, or IL-21, that foster commitment to Th1 or Th17 subsets,
enhance IL-4+TGF-b induced CD4+IL-9+ T cell generation in
presence of pbCD3/sCD28 stimulation.
Materials and Methods
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Institutional Review Board of Beth Israel Deaconess Medical
Center. All adult healthy volunteers provided written informed
consent for the collection of samples at Children’s Hospital Blood
Donor Center, Boston, MA, and for subsequent analysis.
Media, Monoclonal Antibodies, and Cytokines
RPMI 1640 (Gibco, Paisley, Scotland) with L-glutamine was
supplemented with 1% non-essential amino acids, 10% FCS,
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50 U/ml penicillin and 50 mg/ml streptomycin (all from Gibco
BRL, Maryland, USA) and used as culture medium. The following
anti-human mAbs were used: Anti-CD3 (UCHT1) and anti-CD28
(CD28.2); Peridinin chlorophyll protein (PerCP, red fluorescence)
cy5.5 labeled anti-CD4 (BD biosciences); phycoerythrin (PE,
orange fluorescence)-labeled anti-IL-10, anti-IFNc, anti-IL-17,
anti-IL-9 (Biolegend); Alexa-488- or fluorescence isothiocyanate
(FITC, green fluorescence)-labelled anti-FOXP3 and anti-An-
nexin-V (Biolegend). Irrelevant isotype-matched mouse mAbs
were purchased from Biolegend: FITC-IgG1, PE-IgG2a, PE-cy5-
IgG2a, and PerCP-IgG1. Recombinant IL-1b, IL-2, IL-4, IL-6,
IL-12, IL-21, TGF-b, and neutralizing anti-IFNc, -IL-2, and -IL-4
mAb were purchased from R&D.
Preparation of Mononuclear Cells
Leukofilters were obtained from fifteen adult healthy volunteers.
Leukocytes were obtained by back-washing cells from leukofilters
with Dulbecco’s phosphate buffered saline (PBS) (Gibco). CD4+ T
cells were collected from leukocytes using Rosette-sep Human CD4+ T
cell isolation kit (Stemcell technologies) and density gradient
centrifugation on Lymphoprep (Nycomed, Oslo, Norway). The
cells from the interphase were collected and washed three times
with PBS, and trace erythrocytes were removed by hypotonic lysis.
Cell viability as measured by Trypan blue exclusion and the purity
of CD4+ T cell isolation as analyzed by flow cytometry always
exceeded 95%.
Isolation of CD4+CD252 T Cells
Isolated CD4+ T cells were then stained with biotinylated-anti-
CD25 mAb, and CD25+ T cells were depleted using Easy-sep biotin
selection kit (Stemcell technologies). The purity of CD4+CD252 T
cell isolation was always .99%, as analyzed by flow-cytometry.
To isolate naı¨ve CD4+ T cells, CD4+CD252 T cells were stained
with biotinylated–anti-CD45RO mAb and then CD45RO+ T cells
were depleted using Easy-sep biotin selection kits; similarly to isolate
resting memory CD4+ T cells, CD4+CD252 T cells were stained
with biotinylated–anti-CD45RA mAb and CD45RA+ T cells were
depleted using Easy-sep biotin selection kits.
In Vitro Generation of Polarized Human Th1, Th2, Th17,
and iTreg Cells
In cell culture assays, 1.06106/ml CD4+CD252 T cells,
CD4+CD252CD45RA+ T cells, or CD4+CD252CD45RO+ T
cells were activated with 5 mg/ml pbCD3 and 1 mg/ml sCD28 in
culture media at 37uC/5%CO2. To promote CD4+ T cell
differentiation and proliferation, 1.06106/ml CD4+CD252 T cells
were cultured for 4 days in the presence of rIL-2 (1.5ng/ml) and
either rIL-12 (8ng/ml) plus anti-IL-4 mAb (10mg/ml) for Th1-
polarizing conditions or rIL-4 (20ng/ml) plus anti-IFNc mAb
(10mg/ml) for Th2-polarizing conditions, or rhIL-6 (20ng/ml),
rhIL-1b (10ng/ml), anti-IL-4 plus anti-IFNc mAb for Th17-
polarizing conditions, or rTGF-b (1ng/ml) for iTreg-polarizing
condition. The resulting Th1, Th2, Th17 cells were tested for
expression of IFNc, IL-4, IL-17 cytokines by flow cytometry and
expression of Tbet, GATA3, RORC, and FOXP3 transcripts by
quantitative real-time PCR (qt-RT-PCR). In addition, 1.06106/
ml CD4+CD252 T cells, naive CD4+CD252CD45RA+ T cells, or
memory CD4+CD252CD45RO+ T cells were cultured in
presence of pbCD3/sCD28 activation and rIL-4 (20ng/ml)
plus rTGF-b (1ng/ml). In some experiments, memory CD4+
CD252CD45RO+ T cells were activated with pbCD3/sCD28
and IL-4+TGF-b for 96hrs in presence or absence of rhIL-1b
(10ng/ml), rhIL-2 (1.5ng/ml), rhIL-6 (20ng/ml), rIL-12 (8ng/ml),
or rIL-21 (50ng/ml). At 96hrs, supernatants of memory
CD4+CD252CD45RO+ T cell cultures were collected for
quantitation of IFNc, IL-2, IL-5, IL-9, IL-10, IL-13, and IL-17
by ELISA. A portion of cells in these cultures were treated with
RNAlater for quantitation of IL-9 transcripts by qt-RT-PCR, and
the remainder of this cell population was resuspended in FCS
supplemented with 10% DMSO (Sigma) and these cells were
frozen at 280uC until flow-cytometric analysis of the phenotype.
Measurement of Cytokines by ELISA and Intracellular
Ccytokine Staining
Culture supernatants were assessed for cytokine production by
ELISA (Aushon BioSystems). To detect expression of surface or
intracellular proteins, cells were stained with commercial mAb as
per manufacturer’s instructions (eBioscience). Cells were analyzed
by FACScan or LSRII.
RNA Extraction and cDNA Synthesis
Frozen cells were thawed and homogenized using 25-gauge
syringe. Total RNA was extracted using Invitrogen’s Purelink
micro to midi kit (Carlsbad, CA) and the RNA concentration was
measured on Nanodrop ND 1000 spectrophotometer (Wilming-
ton, DE). 1ug of total RNA was converted into cDNA using
Taqman Reverse Transcription kit (Applied Biosystems, NJ)
Quantitative TaqMan Real Time PCR
The ABI PRISM 7900HT Sequence Detection System was
used for qt-RT-PCR analysis. All primer-probe (P&P) sets were
custom designed, except IL-9 and GAPDH (Applied Biosystems).
Custom designed P&P sets were validated by serially diluting
cDNA isolated from cells expressing the target and verifying the
slope, and by sequencing the amplicon. Taqman Fast PCR Master
Mix was purchased from Qiagen (Valencia, CA). Amplification
was carried out in a total volume of 25 ml for 40 cycles of
3 seconds at 95uC, 30 seconds at 60uC. Initial denaturation was
performed for 3 min at 95uC. Target gene expression was
normalized by 18s rRNA (house keeping gene (HKG)) expression.
Single Cell Real-Time PCR
Single cell PCR was performed as per manufacturer’s
instructions (Pre-Amp Cells-to-Ct kit, Applied Biosystems). Briefly,
cultured cells were stained with Annexin-V for live/dead cell
gating and live Annexin-V2 single cells were sorted by FACS-Aria
into 96 well V bottom plate containing 8ml lysis solution
(containing DNAse I). One to 32 cells per well were collected in
triplicates for generating a standard curve for HKG, and cycle
threshold (Ct) value of HKG for a single cell was determined.
Accordingly, test samples with Ct value of HKG that fell in range
of a single cell were chosen for analyzing expression of target
genes. Reverse transcription and pre-amplification were done as
per manufacturer’s instructions. Qt-RT-PCR was performed as
mentioned above. T-bet, GATA3, RORC, IFNc, IL-9, IL-10, IL-
13, IL-17A, and IL-17F transcripts were quantitated on single
CD4+ T cells. We normalized the target gene expression by
GAPDH.
Statistical Analysis
Multiple groups were compared by the non-parametric
Kruskal-Wallis ANOVA; in case p,0.05 was obtained, differences
between pairs of groups were further compared by the Mann-
Whitney U-test or Dunn’s test. When data from only three
independent experiments (n = 3) were analyzed, unpaired t-test
Inducing Human CD4+IL9+T Cells
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with Welch’s correction for unequal variances was used. In any
case, differences were considered statistically significant if p,0.05.
Results and Discussion
IL-4+TGF-b Induces In-Vitro Generation of pbCD3/sCD28
Activated Human CD4+IL-9+ T Cells
IL-9 produced by mouse Tregs mediate recruiting mast cells to
the tissue niche and regulates effector T cells during graft rejection
[13]. Neutralization of IL-9 in vivo in this setting abrogates Treg
cell function and promotes graft rejection [13]. On the other hand,
there is compelling data from the mouse study suggesting the
potentiality of ‘‘Th9’’ cells in inducing colitis and peripheral
neuritis [8]. In humans, in-vitro IL-4+IL-10, in the presence of
anti-CD3 and B7-1/FccRII-transfected fibroblasts, induces naı¨ve
or memory CD4+ T cells to produce IL-9 [14]. However, if this
induction of IL-9 production was dependent or independent of
TGF-b was not examined. Moreover, an assessment of the
expression of lineage specification factors and other cytokines by
human CD4+IL-9+ T cells has not been undertaken. Hence, there
is a need for systematic analysis of human CD4+IL-9+ T cells
differentiation. To address this, we activated freshly isolated
CD4+CD252 T cells for 96hrs with pbCD3/sCD28 in presence or
absence of IL-4 or TGF-b or IL-4+TGF-b. As shown in figure 1A,
IL-4- or TGF-b-alone induced generation of 2% or 4% of
CD4+IL-9+ T cells, whereas no IL-9 was expressed in the absence
of IL-4 or TGF-b. Interestingly, IL-4+TGF-b induced expression
of IL-9 in up to 10% of pbCD3/sCD28 activated CD4+ T cells.
Human resting CD4+ T cells (CD4+CD252 T cells) are
comprised of naı¨ve CD4+CD252CD45RA+ T cells and resting
Figure 1. IL-4+TGF-b in presence of pbCD3/sCD28 activation induce generation of CD4+IL-9+ T cells. A) CD4+CD252 T cells (1.06106/ml
in 24 well plates) were activated with plate bound-anti-CD3 mAb (pbCD3)/soluble-anti-CD28 mAb (sCD28) in presence or absence of IL-4 or TGF-b or
IL-4+TGF-b for 96hrs and analyzed by flow cytometry for IL-9 expression. IL-4+TGF-b in combination induced significantly higher percentage of CD4+
T cells positive for IL-9, as compared to IL-4, TGF-b, or neither (n= 14). Data is expressed as the mean6SD. B) CD4+CD252 T cells,
CD4+CD252CD45RA+ T cells (naı¨ve T cells), CD4+CD252CD45RO+ T cells (resting memory T cells) (2.06105/ml in 96 well plates) were activated with
pbCD3/sCD28 in presence of IL-4+TGF-b in a 96 well plate for 96hrs. Cells were surface stained for CD4 PerCP-Cy5.5 and intracellular stained for IL-9
PE. IL-4+TGF-b in combination induced IL-9 expression by both naı¨ve and memory T cells, but memory T cells expressed high levels of IL-9. Data are
representative of six independent experiments (six different donors).
doi:10.1371/journal.pone.0008706.g001
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memory CD4+CD252CD45RO+ T cells. We separated
CD4+CD252CD45RA+ naı¨ve T cells from CD4+CD252
CD45RO+ resting memory T cells and activated with IL-
4+TGF-b and pbCD3/sCD28 for 96hrs. We found that IL-
4+TGF-b in combination induced IL-9 expression in both naı¨ve
and memory CD4+ T cells, but higher percentage of memory
CD4+ T cells expressed IL-9.
IL-9 is produced by mouse and human Th2 cells [15], and by
mouse nTregs [13]. We then examined for IL-9 production by
human CD4+CD252 T cells cultured in-vitro in Th1-, Th2-, and
Th17-cell polarizing conditions. Robust IL-9 expression was
detected in IL-4+TGF-b treated CD4+CD252 T cells at both
mRNA and protein levels as compared to Th0- (p = 0.0006 and
p = 0.01), Th1- (p = 0.002 and p = 0.001), Th2- (p = 0.002 and
p = 0.04), Th17- (p = 0.001 and p = 0.01) cells, and iTregs
(p = 0.002 and p = 0.04) (Fig 2). To our knowledge, this is the first
report showing IL-9 expression by human iTregs.
Cytokine Profiles of IL-4+TGF-b Treated
CD4+CD252CD45RO+ T Cells
Next, we examined the cytokine profile of these IL-9 producing
resting memory CD4+CD252CD45RO+ T cells 96hrs after in-
vitro stimulation with pbCD3/sCD28 in presence of IL-4+TGF-
b. In this setting, activated memory CD4+CD252CD45RO+ T
cells secreted low levels of IFNc (p = 0.004), IL-13 (p = 0.004), IL-
17 (p = 0.004), IL-5 and IL-10 (not statistically significant) in
comparison to control cultures lacking IL-4+TGF-b, as analyzed
by ELISA (Fig 3A). Note that in the presence of IL-4+TGF-b and
pbCD3/sCD28 stimulation, memory CD4+CD252CD45RO+ T
cells secreted higher levels of IL-2 as compared to control cultures
lacking IL-4+TGF-b (p = 0.008). This suggests a possible role of
IL-2 in maintaining viability of CD4+IL-9+T cells generated from
resting memory CD4+CD252CD45RO+ T cells. As IL-9 is
expressed by human Th2 cells and mouse ‘‘Th9’’ cells produced
IL-10, we hypothesized that TGF-b would synergize with IL-4
in inducing production of all the Th2 cytokines. We found
that TGF-b synergized with IL-4 in elevating IL-9
production, but inhibited IL-4 mediated IL-5, IL-10, and IL-13
production.
CD4+IL-9+ T Cells Express GATA3 and RORC
We probed human CD4+IL-9+ T cells generated from IL-
4+TGF-b stimulated resting memory CD4+CD252CD45RO+ T
cells for expression of the Tbet, GATA3, and RORC lineage
specification transcription factors by pre-amplification boosted
single cell qt-RT-PCR. These CD4+IL-9+ T cells are GATA3+,
RORC+, Tbet2 (Fig 3B), IFNc2, IL-102, IL-132, IL-17A2, and
IL-17F2 (data not shown). In keeping with reports showing that
RORct expression is not limited to Th17 cells [16], we note
expression of RORC, mRNA for RORct, in in-vitro generated
human CD4+IL-9+ T cells, although these cells do not express IL-
17A or IL-17F expression.
IL-4 alone induces GATA3+ Th2 differentiation. We show that
TGF-b doesn’t blunt IL-4 mediated induction of GATA-3
(Fig 3B), yet TGF-b inhibits IL-4 mediated IL-13 expression
(Fig 3A). This suggests that TGF-b acts downstream of GATA-3
to prevent IL-4 mediated IL-13 production. TGF-b, a cytokine
present in many inflammatory states, in combination with the
pro-inflammatory IL-6 cytokine induces generation of inflamma-
tory Th17 cells [7,17]. We now demonstrate that TGF-b and
IL-4, an anti-inflammatory cytokine, induce expression of
human CD4+IL-9+ T cells and inhibit expression of Th2
cytokines.
Figure 2. CD4+CD252 T cells activated with IL-4+TGF-b express
more IL-9 than Th1, Th2, Th17, or iTregs. CD4+CD252 T cells
(1.06106/ml in 24 well plates) were activated with pbCD3/sCD28 in
presence or absence of IL-4+TGF-b or Th1-, Th2-, Th17-, iTreg-polarizing
condition for 96hrs. Cells were harvested, gated on CD4+ T cells, and
were analyzed for IL-9+ cells by flow cytometry or were used to
quantitate IL-9 transcripts by real-time PCR. Data is expressed as the
mean6SD. (A) 2% of Th2 cells, 4% of iTregs, or 10% of cells treated with
IL-4+TGF-b in combination were IL-9+, whereas Th1-, Th17-, or Th0-cells
had negligible number of IL-9+ cells (n= 7); (B) Log-transformed ratios of
IL-9 mRNA copies to 18S rRNA are shown. Cells treated with IL-4+TGF-b
in combination had significantly higher levels of IL-9 mRNA as
compared to polarized Th1-, Th2-, Th17-, iTreg-, or Th0-cells (n= 9).
doi:10.1371/journal.pone.0008706.g002
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Figure 3. Cytokine and transcription factor profile of memory CD4+CD252CD45RO+ T cells activated with IL-4+TGF-b. A) Log-
transformed quantities of cytokines (pg/ml) are shown. CD4+CD252CD45RO+ T cells (1.06106/ml in 24 well plates) were activated with pbCD3/sCD28
in presence or absence of IL-4+TGF-b. Supernatants were collected at 96hrs post activation and IFNc, IL-2, IL-5, IL-9, IL-10, IL-13, and IL-17 were
quantified by ELISA. IL-4+TGF-b treated CD4+ T cells produced significantly high IL-2 and IL-9, but significantly low IFNc, IL-13, and IL-17, as compared
to CD4+CD252CD45RO+ T cells not treated with IL-4+TGF-b (n= 3). Data is expressed as the mean6SD. B) Log-transformed ratios of mRNA copies to
GAPDH mRNA copies for GATA3, RORC, IL-9, and Tbet are shown. CD4+CD252CD45RO+ T cells (1.06106/ml in 24 well plates) were activated with
pbCD3/sCD28 in presence of IL-4+TGF-b. Cells were harvested and single cell sorted. IL-9 transcripts were quantified by qt-RT-PCR. 10,000 cells
comprising of total cell population (TC) was also taken and the gene expression was averaged for single cell for reference. Cells positive for IL-9
transcripts were further quantitated for GATA3, RORC, and Tbet (n= 3). As IL-9 is expressed in only 10% of all CD4+ T cells activated with pbCD3/
sCD28 in presence of IL-4+TGF-b, average IL-9 mRNA copies of TC are always lower than that of a single IL-9+ cell. CD4+IL-9+ T cells expressed GATA3
and RORC, but not Tbet. C) CD4+CD252CD45RO+ T cells (1.06106/ml in 24 well plates) were activated with pbCD3/sCD28 in presence of IL-4+TGF-b.
Cells were surface stained for CD4 and intracellular stained for IL-9 and FOXP3. Cells were gated for CD4 and then IL-9+ or/and FOXP3+ cells were
analyzed. 25% of CD4+IL-9+ T cells were also FOXP3+. Data are representative of seven independent experiments. D) CD4+CD252CD45RO+ T cells
(1.06106/ml in 24 well plates) were activated with pbCD3/sCD28 in presence or absence of IL-4 or TGF-b or IL-4 plus TGF-b for 96hrs and analyzed by
flow cytometry for FOXP3 expression. IL-4 significantly inhibited TGF-b induced FOXP3 expression (n= 3). Data is expressed as the mean6SD.
doi:10.1371/journal.pone.0008706.g003
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As deduced by intracellular staining, approximately 25% of
CD4+IL-9+ T cells are FOXP3+ (Fig 3C). In humans, FOXP3 is
transiently expressed by many in-vitro activated T cells [18] and
iTregs can be generated from both naı¨ve CD4+CD252CD45RA+
T cells and resting memory CD4+CD252CD45RO+ T cells
[18,19]. Among the cell donors, the proportion of memory
CD4+CD252CD45RO+ T cells expressing FOXP3 upon 96 hrs of
pbCD3/sCD28 stimulation in presence of TGF-b was ,20–40%.
Although, IL-4 did not induce FOXP3 expression among memory
CD4+CD252CD45RO+ T cells in presence of pbCD3/sCD28
stimulation, IL-4 inhibited TGF-b induced FOXP3 expression in
this setting (p = 0.025) (Fig 3D) in line with mouse report [8]. This
suggests that IL-4 and TGF-b inhibit each other’s effects, and skew
the cells to CD4+IL-9+ T cells.
Influence of IL-1b, IL-2, IL-6, IL-12, IL-21 on CD4+IL-9+T
Cell Generation
As IL-9 is a pro-inflammatory cytokine, we then hypothesized
that cytokines IL-12, IL-1b, IL-6, and IL21, that induce
inflammatory Th1 or Th17 cell polarization, would enhance IL-
4+TGF-b mediated generation of CD4+IL-9+ T cells in presence
of pbCD3/sCD28 activation. IL-6 did not influence IL-9
secretion. IL-1a and IL-1b induce IL-9 production by activated
murine-CD4+ T cells or -mast cells [15,20]. IL-1b also stimulates
IL-9 production by human eosinophils [21]. Strikingly, we found
that IL-1b, in the presence of IL-4+TGF-b, induced four fold
more IL-9 secretion by IL-4+TGF-b+pbCD3/sCD28-activated
resting memory CD4+ T cells as compared to control cultures
lacking IL-1b (p = 0.0009) (Fig 4). As macrophages are the major
producers of IL-1b, this suggests their plausible role in stimulation
of human CD4+IL-9+ T cells. We examined if IL-1b alone or in
combination with either IL-4 or TGF-b is sufficient to induce IL-9
expression. As analyzed by flow cytometry, IL-4 or TGF-b
induced generation of 2% or 4% of CD4+IL-9+ T cells did not
alter upon adding IL-1b to the cultures, and no IL-9 was expressed
in the presence of IL-1b alone (data not shown). Albeit to a lesser
effect, IL-12 or IL-21 also amplified IL-9 secretion by IL-4+TGF-
b+pbCD3/sCD28-activated memory CD4+CD252CD45RO+ T
cells (p = 0.001 or p = 0.014). As IL-2 was robustly secreted by IL-
4+TGF-b treated resting memory CD4+ T cells (Fig 3A), it is not
totally unexpected that addition of IL-2 to cultures of resting
memory CD4+CD252CD45RO+ T cells activated with pbCD3/
sCD28 and IL-4+TGF-b did not have any significant effect on IL-
9 secretion (Fig 4). Addition of neutralizing anti-IL-2 mAb to
cultures had lead to CD4+ T cell death (data not shown). This data
suggests IL-2 is required to maintain viability of IL-9 producers
and IL-2 may not directly trigger IL-9 expression. Over all, anti-
inflammatory cytokines, IL-4 and TGF-b, induce IL-9 production,
and pro-inflammatory cytokines, IL-1b, IL-12, and IL-21,
enhance IL-9 production.
In conclusion, IL-4+TGF-b, a combination that has proved
effective in generating ‘‘Th9’’ subset in mouse systems, in pbCD3/
sCD28 activated human CD4+CD252CD45RO+ T cells induced
high levels of IL-9 expression. Th2 cells and iTreg were the only
other human CD4+ T cell subsets that expressed IL-9. This study
doesn’t conclude that dual influence of IL-4 and TGF-b in
presence of TCR stimulation and co-stimulation induces human
‘‘Th9’’ cell subset, but like in mouse, does induce CD4+IL-9+ T
cells. Further knowledge of specific-transcription factor and/or
–cell surface marker is required to state these cells as human novel
‘‘Th9’’ cells. With more than one subset of CD4+ T cells producing
IL-9, existence of ‘‘Th9’’ cells as a new subset is debatable. But, so
far both mouse and human results suggest that IL-9 expression is
not devoid of IL-4 or TGF-b stimulation. In-so-far, these CD4+IL-
9+ T cells generated from memory CD4+ T cells are different from
mouse CD4+IL-9+ T cells generated from naı¨ve CD4+ T cells in
the following aspects: 1) human CD4+IL-9+ T cells express
GATA3 and RORC; 2) some human CD4+IL-9+ T cells express
FOXP3 and; 3) human CD4+IL-9+ T cells do not express IL-10.
On the other hand, this study shows certain similarities between
mouse and human systems, where like in mouse, human CD4+IL-
9+ T cells do not express Tbet, IFNc, IL-5, and IL-13 and; IL-4
inhibits TGF-b induced FOXP3 expression. We did not address if
human CD4+IL-9+ T cells are functionally effector cells like in
mouse. Attempts to optimize IL-9 production by pbCD3/sCD28
and IL-4+TGF-b stimulated resting memory CD4+ T cells
demonstrated that the addition of enhances IL-9 production.
These data revive the potent influence of pro-inflammatory
cytokines IL-1b, IL-12, and IL-21 to modulate the response of
antigen activated CD4+ T cells.
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Figure 4. IL-1b amplifies IL-4+TGF-b induced IL-9 production
by memory CD4+CD252CD45RO+ T cells. Resting memory
CD4+CD252CD45RO+ T cells (2.06105/ml in 96 well plates) activated
with pbCD3/sCD28 alone or with IL-4+TGF-b, in the presence or
absence of IL-1b, IL-2, IL-6, IL-12, and IL-21 for 96hrs and supernatants
were collected. Influence of IL-1b, IL-2, IL-6, IL-12, and IL-21 on IL-9
production of IL-4+TGF-b treated CD4+CD252CD45RO+ T cells was
examined. IL-1b, IL-12 or IL-21 significantly elevated IL-4+TGF-b
induced IL-9 production, but IL-1b had significantly higher influence
compared to IL-12 or IL-21 (n = 3). Data is expressed as the mean6
SD.
doi:10.1371/journal.pone.0008706.g004
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